Evidence map›Paper›PMID 33420513›Full record

ArticleMammalian genome : official journal of the International Mammalian Genome Society2021

The ring finger protein 213 gene (Rnf213) contributes to Rift Valley fever resistance in mice.

Denis Houzelstein, Dominique Simon-Chazottes, Leandro Batista, Satoko Tokuda, Francina Langa Vives, Marie Flamand, Xavier Montagutelli, Jean-Jacques Panthier

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. RNF213-dependent lytic destruction ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. TheeLife · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. ThebioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Insights into non-proteinaceous ubiquitination.Biochemical Society transactions · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Denis HouzelsteinMouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France. denis.houzelstein@pasteur.fr.ORCID 0000-0002-8536-9039
Dominique Simon-ChazottesMouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.
Leandro BatistaMouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.
Satoko TokudaMouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.
Francina Langa VivesMouse Genetics Engineering, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.ORCID 0000-0002-0801-5464
Marie FlamandStructural Virology, Department of Virology, Institut Pasteur, 75015, Paris, France.
Xavier Montagutelli *Mouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.ORCID 0000-0002-9372-5398
Jean-Jacques Panthier *Mouse Functional Genetics, Department of Developmental & Stem Cell Biology, Institut Pasteur, 75015, Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rift Valley fever (RVF) is an emerging viral zoonosis that primarily affects ruminants and humans. We have previously shown that wild-derived MBT/Pas mice are highly susceptible to RVF virus and that part of this phenotype is controlled by a locus located on distal Chromosome 11. Using congenic strains, we narrowed down the critical interval to a 530 kb region containing five protein-coding genes among which Rnf213 emerged as a potential candidate. We generated Rnf213-deficient mice by CRISPR/CAS9 on the C57BL/6 J background and showed that they were significantly more susceptible to RVF than control mice, with an average survival time post-infection reduced from 7 to 4 days. The human RNF213 gene had been associated with the cerebrovascular Moyamoya disease (MMD or MYMY) but the inactivation of this gene in the mouse resulted only in mild anomalies of the neovascularization. This study provides the first evidence that the Rnf213 gene may also impact the resistance to infectious diseases such as RVF.

Indexed as

Adenosine TriphosphatasesAnimalsChromosome MappingCRISPR-Cas SystemsDisease Models, AnimalDisease ResistanceHost-Pathogen InteractionsMiceMice, Inbred C57BLMice, KnockoutRift Valley FeverRift Valley fever virusUbiquitin-Protein LigasesAdenosine TriphosphatasesRNF213 protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID33420513
OpenAlexW3120550654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.